Editas Medicine Inc EDIT

NAS: EDIT | ISIN: US28106W1036 30/04/2025

1,650 USD (+6,45%)

(+6,45%) 30/04/2025

Toon enkel gratis nieuws

27 juli 2023 · Editas Medicine and Azzur Group Expand Partnership to Accelerate Editas' Manufacturing Capabilities for Advancing the EDIT-301 Program Through Approval to Commercialization · Persbericht

18 februari 2021 · Editas Medicine to Host Conference Call Discussing Fourth Quarter and Full Year 2020 Results and Corporate Update · Persbericht

21 januari 2021 · Editas Medicine Announces Pricing of Offering of Common Stock · Persbericht

19 januari 2021 · Editas Medicine Announces Offering of Common Stock · Persbericht

11 januari 2021 · Editas Medicine Reports on Recent Progress and Outlook at J.P. Morgan Healthcare Conference · Persbericht

11 januari 2021 · Editas Medicine Announces the FDA has Cleared Initiation of the EDIT-301 Clinical Trial · Persbericht

11 januari 2021 · Editas Medicine Announces Transition of Chief Scientific Officer · Persbericht

4 januari 2021 · Editas Medicine to Present at the 39th Annual J.P. Morgan Healthcare Conference · Persbericht

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe